APA (7th ed.) Citation

Korn, S., Bourdin, A., Chupp, G., Cosio, B. G., Arbetter, D., Shah, M., & Gil, E. G. (2021). Integrated safety and efficacy among patients receiving Benralizumab for Up to 5 Years. The journal of allergy and clinical immunology. In practice, 9(12), . https://doi.org/10.1016/j.jaip.2021.07.058

Chicago Style (17th ed.) Citation

Korn, Stephanie, Arnaud Bourdin, Geoffrey Chupp, Borja G. Cosio, Doug Arbetter, Mihir Shah, and Esther Garcia Gil. "Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years." The Journal of Allergy and Clinical Immunology. In Practice 9, no. 12 (2021). https://doi.org/10.1016/j.jaip.2021.07.058.

MLA (9th ed.) Citation

Korn, Stephanie, et al. "Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years." The Journal of Allergy and Clinical Immunology. In Practice, vol. 9, no. 12, 2021, https://doi.org/10.1016/j.jaip.2021.07.058.